About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [282 citations: 1–100 of 255 articles]

Articles published in Schizophrenia Research and Treatment have been cited 282 times. The following is a list of the 255 articles that have cited the articles published in Schizophrenia Research and Treatment.

  • M. Möller, T. Swanepoel, and B. H. Harvey, “Neurodevelopmental Animal Models Reveal the Convergent Role of Neurotransmitter Systems, Inflammation, and Oxidative Stress as Biomarkers of Schizophrenia: Implications for Novel Drug Development,” ACS Chemical Neuroscience, pp. 150402134223006, 2015. View at Publisher · View at Google Scholar
  • A. L. Sutterland, G. Fond, A. Kuin, M. W. J. Koeter, R. Lutter, T. van Gool, R. Yolken, A. Szoke, M. Leboyer, and L. de Haan, “ Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis ,” Acta Psychiatrica Scandinavica, 2015. View at Publisher · View at Google Scholar
  • Anne Gut-Fayand, “Éducation thérapeutique du patient et schizophrénies débutantes,” Annales Médico-psychologiques, revue psychiatrique, 2015. View at Publisher · View at Google Scholar
  • Federica Pinna, Luca Deriu, Enrica Diana, Valeria Perra, Rachele Pisu Randaccio, Lucia Sanna, Massimo Tusconi, and Bernardo Carpiniello, “Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders,” Annals of General Psychiatry, vol. 14, no. 1, 2015. View at Publisher · View at Google Scholar
  • Kiran Jakhar, Triptish Bhatia, Rahul Saha, and Smita Deshpande, “A Cross Sectional Study of Prevalence and Correlates of Current and Past Risks in Schizophrenia,” Asian Journal of Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Christina Daniel, and Oliver J. Mason, “Predicting Psychotic-Like Experiences during Sensory Deprivation,” BioMed Research International, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Zhi Zhang, and Henriette van Praag, “Maternal immune activation differentially impacts mature and adult-born hippocampal neurons in male mice,” Brain, Behavior, and Immunity, vol. 45, pp. 60–70, 2015. View at Publisher · View at Google Scholar
  • Marjolaine Masson, Til Wykes, Michel Maziade, Clare Reeder, Marie-Anne Gariépy, Marc-André Roy, Hans Ivers, and Caroline Cellard, “Top-Down Computerized Cognitive Remediation in Schizophrenia: A Case Study of an Individual with Impairment in Verbal Fluency,” Case Reports in Psychiatry, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • lement Zai Ali Bani Fatemi C, and Vincenzo De Luca, “Early Onset Schizophrenia: Gender Analysis of Genome-Wide Potential Methylation,” Clinica Chimica Acta, 2015. View at Publisher · View at Google Scholar
  • Katherine L. Narr, and Amber M. Leaver, “Connectome and schizophrenia,” Current Opinion in Psychiatry, vol. 28, no. 3, pp. 229–235, 2015. View at Publisher · View at Google Scholar
  • Foteini Tseliou, Sonia Johnson, Barnaby Major, Nikola Rahaman, John Joyce, Jo Lawrence, Farhana Mann, Andrew Tapfumaneyi, Brock Chisholm, Nick Chamberlain-Kent, Mark F. Hinton, and Helen L. Fisher, “Gender differences in one-year outcomes of first-presentation psychosis patients in inner-city UK Early Intervention Services,” Early Intervention in Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Shirlene Pang, Mythily Subramaniam, Edimansyah Abdin, Lye Yin Poon, Siow Ann Chong, and Swapna Verma, “Gender differences in patients with first-episode psychosis in the Singapore Early Psychosis Intervention Programme,” Early Intervention in Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Ruth A. Lanius, Paul A. Frewen, Mischa Tursich, Rakesh Jetly, and Margaret C. McKinnon, “Restoring large-scale brain networks in PTSD and related disorders: a proposal for neuroscientifically-informed treatment interventions,” European Journal of Psychotraumatology, vol. 6, no. 0, 2015. View at Publisher · View at Google Scholar
  • B. Chiliza, L. Asmal, P. Oosthuizen, E. Van Niekerk, R. Erasmus, M. Kidd, A. Malhotra, and R. Emsley, “Changes in body mass and metabolic profiles in patients with first-episode schizophrenia treated for 12 months with a first-generation antipsychotic,” European Psychiatry, vol. 30, no. 2, 2015. View at Publisher · View at Google Scholar
  • S. Ittig, E. Studerus, M. Papmeyer, M. Uttinger, S. Koranyi, A. Ramyead, and A. Riecher-Roessler, “Sex differences in cognitive functioning in at-risk mental state for psychosis, first episode psychosis and healthy control subjects,” European Psychiatry, vol. 30, no. 2, 2015. View at Publisher · View at Google Scholar
  • Mikael Mokkonen, and Bernard J. Crespi, “Genomic conflicts and sexual antagonism in human health: insights from oxytocin and testosterone,” Evolutionary Applications, 2015. View at Publisher · View at Google Scholar
  • Jan Malte Bumb, Frank Enning, and F Markus Leweke, “Drug repurposing and emerging adjunctive treatments for schizophrenia,” Expert Opinion on Pharmacotherapy, pp. 1–19, 2015. View at Publisher · View at Google Scholar
  • J. Zhang, L. Ye, W. Wang, G. Du, X. Yu, X. Zhu, Q. Dong, X. Cen, X. Guan, F. Fu, and J. Tian, “A 12-week subchronic intramuscular toxicity study of risperidone-loaded microspheres in rats,” Human & Experimental Toxicology, vol. 34, no. 2, pp. 205–223, 2015. View at Publisher · View at Google Scholar
  • Lucia Margari, Emilia Matera, Maria G. Petruzzelli, Marta Simone, Anna L. Lamanna, Adriana Pastore, Vincenzo O. Palmieri, and Francesco Margari, “Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents,” International Clinical Psychopharmacology, vol. 30, no. 2, pp. 103–108, 2015. View at Publisher · View at Google Scholar
  • Sai Krishna Tikka, S. Haque Nizamie, Nishant Goyal, N. Pradhan, Deyashini Lahiri Tikka, and Mohammad Zia Ul Haq Katshud, “Evaluation of spontaneous dense array gamma oscillatory activity and minor physical anomalies as a composite neurodevelopmental endophenotype in schiz,” International Journal Of Developmental Neuroscience, vol. 40, pp. 43–51, 2015. View at Publisher · View at Google Scholar
  • Greet Wilrycx, Marcel Croon, Anneloes Van den Broek, and Chijs van Nieuwenhuizen, “Evaluation of a recovery-oriented care training program for mental healthcare professionals: Effects on mental health consumer outcomes,” International Journal Of Social Psychiatry, vol. 61, no. 2, pp. 164–173, 2015. View at Publisher · View at Google Scholar
  • Steffen Moritz, Anja S. Göritz, Jürgen Gallinat, Milena Schafschetzy, Niels Van Quaquebeke, Maarten J.V. Peters, and Christina Andreou, “Subjective competence breeds overconfidence in errors in psychosis. A hubris account of paranoia,” Journal of Behavior Therapy and Experimental Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Alexandre González-Rodríguez, Oriol Molina-Andreu, Rafael Penadés, Miquel Bernardo, and Rosa Catalán, “Therapeutic Approach to Delusional Disorder Based on Psychopathological Complexity,” Journal of Clinical Psychopharmacology, vol. 35, no. 2, pp. 201–202, 2015. View at Publisher · View at Google Scholar
  • Yun Xiu, Xiang-ru Kong, Lei Zhang, Xuan Qiu, Yuan Gao, Chun-xia Huang, Feng-lei Chao, San-rong Wang, and Yong Tang, “The myelinated fiber loss in the corpus callosum of mouse model of schizophrenia induced by MK-801,” Journal of Psychiatric Research, 2015. View at Publisher · View at Google Scholar
  • T Lencz, and A K Malhotra, “Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic,” Molecular Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Gen Yan, Yinghua Xuan, Zhuozhi Dai, Zhiwei Shen, Guishan Zhang, Haiyun Xu, and Renhua Wu, “Brain Metabolite Changes in Subcortical Regions After Exposure to Cuprizone for 6 Weeks: Potential Implications for Schizophrenia,” Neurochemical Research, vol. 40, no. 1, pp. 49–58, 2015. View at Publisher · View at Google Scholar
  • TianMei Si, QingRong Tan, KeRang Zhang, Yang Wang, and Qing Rui, “An open-label, flexible-dose study of paliperidone extended-release in Chinese patients with first-onset psychosis,” Neuropsychiatric Disease And Treatment, vol. 11, pp. 87–95, 2015. View at Publisher · View at Google Scholar
  • Ping Yang, Zhenyong Gao, Handi Zhang, Zeman Fang, Cairu Wu, Haiyun Xu, and Qing-Jun Huang, “Changes in proinflammatory cytokines and white matter in chronically stressed rats,” Neuropsychiatric Disease And Treatment, vol. 11, pp. 597–607, 2015. View at Publisher · View at Google Scholar
  • Caroline Cellard, Clare Reeder, Andrée-Anne Paradis-Giroux, Marc-André Roy, Elsa Gilbert, Hans Ivers, Roch-Hugo Bouchard, Michel Maziade, and Til Wykes, “A feasibility study of a new computerised cognitive remediation for young adults with schizophrenia,” Neuropsychological Rehabilitation, pp. 1–24, 2015. View at Publisher · View at Google Scholar
  • Colin Martin, Matthew Witt, Kathryn Puskar, Cynthia Slivka, and Heeyoung Lee, “A Case Study on Promoting Neuroplasticity in a Patient With Schizophrenia,” Perspectives in Psychiatric Care, 2015. View at Publisher · View at Google Scholar
  • Choochart Wong-Anuchit, “Clinical Management of Antipsychotic-Induced Hyperprolactinemia,” Perspectives in Psychiatric Care, 2015. View at Publisher · View at Google Scholar
  • Kudrat Randhawa, Deepak Kumar, Anupam Jamwal, and Suresh Kumar, “ Screening of antidepressant activity and estimation of quercetin from Coccinia indica using TLC densitometry ,” Pharmaceutical Biology, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Lorenz Deutschenbaur, Johannes Beck, Anna Kiyhankhadiv, Markus Mühlhauser, Stefan Borgwardt, Marc Walter, Gregor Hasler, Daniel Sollberger, and Undine E. Lang, “Role of Calcium, Glutamate and NMDA in major depression and therapeutic application,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Stavroula I. Bargiota, Konstantinos Bonotis, Ioannis E. Messinis, Georgios Garyfallos, and Nikiforos V. Angelopoulos, “Hyperprolactinaemia: Psychological aspects and menstrual attitudes of women with schizophrenia,” Psychiatry Research, 2015. View at Publisher · View at Google Scholar
  • Cristiana Montemagni, Tiziana Frieri, Arianna Blandamura, Vincenzo Villari, and Paola Rocca, “Gender differences in 353 inpatients with acute psychosis: The experience of one Psychiatric Emergency Service of Turin,” Psychiatry Research, 2015. View at Publisher · View at Google Scholar
  • Barbara Remberk, Anna Katarzyna Bazynska, Zofia Bronowska, Pawel Potocki, Anna Krempa-Kowalewska, Piotr Niwinski, and Filip Rybakowski, “Which Aspects of Long-Term Outcome Are Predicted by Positive and Negative Symptoms in Early-Onset Psychosis? An Exploratory Eight-Year Follow-Up Study,” Psychopathology, vol. 48, no. 1, pp. 47–55, 2015. View at Publisher · View at Google Scholar
  • Joanna M. Wieronska, Anna Slawinska, Magdalena Lason-Tyburkiewicz, Piotr Gruca, Mariusz Papp, Stevin H. Zorn, Dario Doller, Natalia Kleczek, Karolina Noworyta-Sokolowska, Krystyna Golembiowska, and Andrzej Pilc, “The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT1A receptor signaling: mechanistic studies,” Psychopharmacology, vol. 232, no. 1, pp. 259–273, 2015. View at Publisher · View at Google Scholar
  • Martina Fieker, and Brooke C. Schneider, “Metakognitives Training bei Schizophrenie,” Psychotherapeut, 2015. View at Publisher · View at Google Scholar
  • M. Aurora Falcone, Robin M. Murray, Benjamin D. R. Wiffen, Jennifer A. O'Connor, Manuela Russo, Anna Kolliakou, Simona Stilo, Heather Taylor, Poonam Gardner-Sood, Alessandra Paparelli, Fatima Jichi, Marta Di Forti, Anthony S. David, Daniel Freeman, and Suzanne Jolley, “Jumping to Conclusions, Neuropsychological Functioning, and Delusional Beliefs in First Episode Psychosis,” Schizophrenia Bulletin, vol. 41, no. 2, pp. 411–418, 2015. View at Publisher · View at Google Scholar
  • Ofer Pasternak, Carl-Fredrik Westin, Brian Dahlben, Sylvain Bouix, and Marek Kubicki, “The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia,” Schizophrenia Research, vol. 161, no. 1, pp. 113–118, 2015. View at Publisher · View at Google Scholar
  • Souhel Najjar, and Daniel M. Pearlman, “Neuroinflammation and white matter pathology in schizophrenia: systematic review,” Schizophrenia Research, vol. 161, no. 1, pp. 102–112, 2015. View at Publisher · View at Google Scholar
  • Kazuteru Egashira, Koji Matsuo, Mami Nakashima, Toshio Watanuki, Kenichiro Harada, Masayuki Nakano, Toshio Matsubara, Kanji Takahashi, and Yoshifumi Watanabe, “Blunted brain activation in patients with schizophrenia in response to emotional cognitive inhibition: A functional near-infrared spectroscopy study,” Schizophrenia Research, 2015. View at Publisher · View at Google Scholar
  • Robert A. Renes, Anouk van der Weiden, Merel Prikken, René S. Kahn, Henk Aarts, and Neeltje E.M. van Haren, “Abnormalities in the experience of self-agency in schizophrenia: A replication study,” Schizophrenia Research, 2015. View at Publisher · View at Google Scholar
  • George C. Nitzburg, Katherine E. Burdick, Anil K. Malhotra, and Pamela DeRosse, “Social cognition in patients with schizophrenia spectrum and bipolar disorders with and without psychotic features,” Schizophrenia Research: Cognition, 2015. View at Publisher · View at Google Scholar
  • Ana Barajas, Susana Ochoa, Jordi E. Obiols, and Lluís Lalucat-Jo, “Gender Differences in Individuals at High-Risk of Psychosis: A Comprehensive Literature Review,” The Scientific World Journal, vol. 2015, pp. 1–13, 2015. View at Publisher · View at Google Scholar
  • Louise B. Glenthoj, Birgitte Fagerlund, Lasse Randers, Carsten R. Hjorthoj, Christina Wenneberg, Kristine Krakauer, Astrid Vosgerau, Christian Gluud, Alice Medalia, David L. Roberts, and Merete Nordentoft, “The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol,” Trials, vol. 16, 2015. View at Publisher · View at Google Scholar
  • J. Long, G. Huang, W. Liang, B. Liang, Q. Chen, J. Xie, J. Jiang, and L. Su, “The prevalence of schizophrenia in mainland China: evidence from epidemiological surveys,” Acta Psychiatrica Scandinavica, 2014. View at Publisher · View at Google Scholar
  • Jin Dang, Jiangtao Zhang, Zhongwei Guo, Weihong Lu, Jun Cai, Zhongying Shi, and Chen Zhang, “A Pilot Study of iPad-assisted Cognitive Training for Schizophrenia,” Archives of Psychiatric Nursing, 2014. View at Publisher · View at Google Scholar
  • Hatice Durmaz, and Ayşe Okanlı, “Investigation of the Effect of Self-Efficacy Levels of Caregiver Family Members of the Individuals With Schizophrenia on Burden of Care,” Archives of Psychiatric Nursing, 2014. View at Publisher · View at Google Scholar
  • Zoltán Sarnyai, Cassandra Jashar, and Berend Olivier, “Modeling combined schizophrenia-related behavioral and metabolic phenotypes in rodents,” Behavioural Brain Research, 2014. View at Publisher · View at Google Scholar
  • Heline Mirzakhanian, Fiza Singh, and Kristin S. Cadenhead, “Biomarkers in psychosis: an approach to early identification and individualized treatment,” Biomarkers in Medicine, vol. 8, no. 1, pp. 51–57, 2014. View at Publisher · View at Google Scholar
  • Ajeet B Singh, Andrew A Nierenberg, Lakshmi N Yatham, and Michael Berk, “Atypical antipsychotic agents; Peas in a pod or chalk and cheese?,” BMC Medicine, vol. 12, no. 1, pp. 126, 2014. View at Publisher · View at Google Scholar
  • Carmen Miralles, Yolanda Alonso, Begona Verge, Sonia Seto, Ana M. Gaviria, Lorena Moreno, Maria J. Cortes, Alfonso Gutierrez-Zotes, Elisabet Vilella, and Lourdes Martorell, “Personality dimensions of schizophrenia patients compared to control subjects by gender and the relationship with illness severity,” Bmc Psychiatry, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Bess Y. H. Lam, Adrian Raine, and Tatia M. C. Lee, “The relationship between neurocognition and symptomatology in people with schizophrenia: social cognition as the mediator,” Bmc Psychiatry, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Robyn Langdon, Michael H. Connors, Megan Still, Philip B. Ward, and Stanley Catts, “Theory of mind and neurocognition in early psychosis: a quasi-experimental study,” Bmc Psychiatry, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Xiao Chang, Hui Shen, Lubin Wang, Zhening Liu, Wei Xin, Dewen Hu, and Danmin Miao, “Altered default mode and fronto-parietal network subsystems in patients with schizophrenia and their unaffected siblings,” Brain Research, vol. 1562, pp. 87–99, 2014. View at Publisher · View at Google Scholar
  • Simon Ketteler, Daniel Ketteler, René Vohn, Frank Kastrau, Jörg B. Schulz, Kathrin Reetz, and Walter Huber, “The processing of lexical ambiguity in healthy ageing and Parkinson׳s disease: Role of cortico-subcortical networks,” Brain Research, 2014. View at Publisher · View at Google Scholar
  • Christine Lycke Brandt, Tom Eichele, Ingrid Melle, Kjetil Sundet, Andres Server, Ingrid Agartz, Kenneth Hugdahl, Jimmy Jensen, and Ole A. Andreassen, “Working memory networks and activation patterns in schizophrenia and bipolar disorder: comparison with healthy controls,” British Journal of Psychiatry, vol. 204, no. 4, pp. 290–298, 2014. View at Publisher · View at Google Scholar
  • S. Jauhar, P. J. McKenna, J. Radua, E. Fung, R. Salvador, and K. R. Laws, “Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias,” British Journal of Psychiatry, vol. 204, no. 1, pp. 20–29, 2014. View at Publisher · View at Google Scholar
  • Vaios Peritogiannis, Thiresia Manthopoulou, and Venetsanos Mavreas, “First Episode of Psychosis in a Middle-Aged Patient with a 14-Year History of Conversion Disorder,” Case Reports in Psychiatry, vol. 2014, pp. 1–5, 2014. View at Publisher · View at Google Scholar
  • Steffen Moritz, Christina Andreou, Brooke C. Schneider, Charlotte E. Wittekind, Mahesh Menon, Ryan P. Balzan, and Todd S. Woodward, “Sowing the seeds of doubt: a narrative review on metacognitive training in schizophrenia,” Clinical Psychology Review, 2014. View at Publisher · View at Google Scholar
  • Tania M. Lincoln, Carolin Möbius, Martin T. Huber, Matthias Nagel, and Steffen Moritz, “Frequency and correlates of maladaptive responses to paranoid thoughts in patients with psychosis compared to a population sample,” Cognitive Neuropsychiatry, pp. 1–18, 2014. View at Publisher · View at Google Scholar
  • Tania M. Lincoln, Jonas Stahnke, and Steffen Moritz, “The Short-Term Impact of a Paranoid Explanation on Self-esteem: An Experimental Study,” Cognitive Therapy and Research, 2014. View at Publisher · View at Google Scholar
  • Barbara Remberk, Anna Katarzyna Bażyńska, Anna Krempa-Kowalewska, and Filip Rybakowski, “Adolescent insanity revisited: Course and outcome in early-onset schizophrenia spectrum psychoses in an 8-year follow-up study,” Comprehensive Psychiatry, vol. 55, no. 5, pp. 1174–1181, 2014. View at Publisher · View at Google Scholar
  • Marie-Hélène Lafeuille, Jason Dean, Valerie Carter, Mei Sheng Duh, John Fastenau, Riad Dirani, and Patrick Lefebvre, “Systematic Review of Long-Acting Injectables versus Oral Atypical Antipsychotics on Hospitalization in Schizophrenia,” Current Medical Research and Opinion, pp. 1–43, 2014. View at Publisher · View at Google Scholar
  • Christy L.-M. Hui, Chung-Ming Leung, Wing-Chung Chang, Sherry K.-W. Chan, Edwin H.-M. Lee, and Eric Y.-H. Chen, “Examining gender difference in adult-onset psychosis in Hong Kong,” Early Intervention in Psychiatry, 2014. View at Publisher · View at Google Scholar
  • Nedah Hassanali, Tamatha Ruffell, Sophie Browning, Karen Bracegirdle, Catherine Ames, Richard Corrigall, Kristin R. Laurens, Colette Hirsch, Elizabeth Kuipers, Lucy Maddox, and Suzanne Jolley, “Cognitive bias and unusual experiences in childhood,” European Child & Adolescent Psychiatry, 2014. View at Publisher · View at Google Scholar
  • Steffen Moritz, Alexandra Hünsche, and Tania M. Lincoln, “Nonadherence for antipsychotics: The role of positive attitudes towards positive symptoms,” European Neuropsychopharmacology, 2014. View at Publisher · View at Google Scholar
  • John D. Salamone, Ivan Koychev, Mercè Correa, and Philip McGuire, “Neurobiological basis of motivational deficits in psychopathology,” European Neuropsychopharmacology, 2014. View at Publisher · View at Google Scholar
  • Elena Huerta-Ramos, Raquel Iniesta, Susana Ochoa, Jesus Cobo, Eva Miquel, Mercedes Roca, Antoni Serrano-Blanco, Fernando Teba, and Judith Usall, “Effects of raloxifene on cognition in postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial,” European Neuropsychopharmacology, vol. 24, no. 2, pp. 223–231, 2014. View at Publisher · View at Google Scholar
  • Dolores Malaspina, Julie Walsh-Messinger, Wolfgang Gaebel, Lianne Morris Smith, Alyson Gorun, Vasthie Prudent, Daniel Antonius, and Fabien Tremeau, “Negative symptoms, past and present: A historical perspective and moving to DSM-5,” European Neuropsychopharmacology, vol. 24, no. 5, pp. 710–724, 2014. View at Publisher · View at Google Scholar
  • J.-P. Klemettilä, O. Kampman, N. Seppälä, M. Viikki, M. Hämäläinen, E. Moilanen, N. Mononen, T. Lehtimäki, and E. Leinonen, “Association study of the HTR2C, leptin and adiponectin genes and serum marker analyses in clozapine treated long-term patients with schizophrenia,” European Psychiatry, 2014. View at Publisher · View at Google Scholar
  • Marc De Hert, Johan Detraux, and Joseph Peuskens, “Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review,” Expert Opinion on Drug Safety, pp. 1–20, 2014. View at Publisher · View at Google Scholar
  • Luisa-Sophie Köster, Maren Carbon, and Christoph U Correll, “Emerging drugs for schizophrenia: an update,” Expert Opinion on Emerging Drugs, pp. 1–21, 2014. View at Publisher · View at Google Scholar
  • Larry Alphs, Cynthia A. Bossie, Dong-Jing Fu, Yi-Wen Ma, and Jennifer Kern Sliwa, “Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia,” Expert Opinion on Pharmacotherapy, vol. 15, no. 7, pp. 1029–1042, 2014. View at Publisher · View at Google Scholar
  • W. Woelwer, A. Lowe, and N. Frommann, “Training of Social-Cognitive Functions - New Approaches towards the Avoidance of Psychosocial Disabilities in Schizophrenia,” Fortschritte der Neurologie Psychiatrie, vol. 82, no. 4, pp. 203–209, 2014. View at Publisher · View at Google Scholar
  • Myrthel Dogge, Dennis Hofman, Maria Boersma, H. Chris Dijkerman, and Henk Aarts, “Cortical information flow during inferences of agency,” Frontiers in Human Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Eric E. Schadt, Sean Buchanan, Kristen J. Brennand, and Kalpana M. Merchant, “Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders,” Frontiers in Pharmacology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Else-Marie Løberg, Siri Helle, Merethe NygÃ¥rd, Jan Øystein Berle, Rune A. Kroken, and Erik Johnsen, “The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability,” Frontiers in Psychiatry, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Julie Champagne, Adrianna Mendrek, Martine Germain, Pascal Hot, and Marc E. Lavoie, “Event-related brain potentials to emotional images and gonadal steroid hormone levels in patients with schizophrenia and paired controls,” Frontiers in Psychology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Thibaut Dondaine, Gabriel Robert, Julie Péron, Didier Grandjean, Marc Vérin, Dominique Drapier, and Bruno Millet, “Biases in facial and vocal emotion recognition in chronic schizophrenia,” Frontiers in Psychology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Richard Uwakwe, and Alex Otakpor, “Public Mental Health – Using the Mental Health Gap Action Program to Put all Hands to the Pumps,” Frontiers in Public Health, vol. 2, 2014. View at Publisher · View at Google Scholar
  • Brenda Valeiras, Maria Victoria Rosato Siri, Martin Codagnone, Analia Reines, and Juana Maria Pasquini, “Gender Influence on Schizophrenia-Relevant Abnormalities in a Cuprizone Demyelination Model,” Glia, vol. 62, no. 10, pp. 1629–1644, 2014. View at Publisher · View at Google Scholar
  • V. Haroutunian, P. Katsel, P. Roussos, K. L. Davis, L. L. Altshuler, and G. Bartzokis, “Myelination, oligodendrocytes, and serious mental illness,” Glia, 2014. View at Publisher · View at Google Scholar
  • Carol Curtin, Mirjana Jojic, and Linda G. Bandini, “Obesity in Children with Autism Spectrum Disorder,” Harvard Review of Psychiatry, vol. 22, no. 2, pp. 93–103, 2014. View at Publisher · View at Google Scholar
  • Dong-Jing Fu, Cynthia A. Bossie, Jennifer K. Sliwa, Yi-Wen Ma, and Larry Alphs, “Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison,” International Clinical Psychopharmacology, vol. 29, no. 1, pp. 45–55, 2014. View at Publisher · View at Google Scholar
  • Nam Young Lee, Se Hyun Kim, Seong Jin Cho, Young-Cho Chung, In Kwa Jung, Chang Yoon Kim, Duk Ho Kim, Dong Geun Lee, Yo Han Lee, Weon Jeong Lim, Young Suk Na, Sang Eun Shin, Jong-Min Woo, Jin Sang Yoon, Bo-Hyun Yoon, Yong Min Ahn, and Yong Sik Kim, “A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea,” International Clinical Psychopharmacology, vol. 29, no. 5, pp. 279–287, 2014. View at Publisher · View at Google Scholar
  • S. Gopal, H. Xu, C. Bossie, J. A. Buron, D. J. Fu, A. Savitz, I. Nuamah, and D. Hough, “Incidence of tardive dyskinesia: a comparison of long-acting injectable and oral paliperidone clinical trial databases,” International Journal of Clinical Practice, vol. 68, no. 12, pp. 1514–1522, 2014. View at Publisher · View at Google Scholar
  • Brian Dean, Hans-Juergen Moller, Torgny H. Svensson, Mark A. Geyer, Dan Rujescu, Elizabeth Scarr, and Mark J. Millan, “Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank,” International Journal of Neuropsychopharmacology, vol. 17, no. 1, pp. 137–148, 2014. View at Publisher · View at Google Scholar
  • Pavel Mohr, Mabel Rodriguez, Anna Bravermanova, Tomas Melicher, Zuzana Ceplova, Jan Cermak, and Jan Pecenak, “Social and functional capacity of schizophrenia patients: A cross-sectional study,” International Journal of Social Psychiatry, vol. 60, no. 4, pp. 352–358, 2014. View at Publisher · View at Google Scholar
  • Oluyomi Esan, and Olufunmilayo I. Fawole, “Acute and transient psychotic disorder in a developing country,” International Journal of Social Psychiatry, vol. 60, no. 5, pp. 442–448, 2014. View at Publisher · View at Google Scholar
  • Joseph R. Calabrese, Maurizio Fava, George Garibaldi, Heinz Grunze, Andrew D. Krystal, Thomas Laughren, Wayne Macfadden, Robert Marin, Andrew A. Nierenberg, and Mauricio Tohen, “Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders,” Journal of Affective Disorders, vol. 168, pp. 439–451, 2014. View at Publisher · View at Google Scholar
  • Larry Alphs, Lian Mao, Stephen C. Rodriguez, Joe Hulihan, and H. Lynn Starr, “Design and Rationale of the Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) Study: A Novel Comparative Trial of Once-Monthly Pa,” Journal Of Clinical Psychiatry, vol. 75, no. 12, pp. 1388–1393, 2014. View at Publisher · View at Google Scholar
  • Carol L.M. Caton, Haiyi Xie, Robert E. Drake, and Gregory McHugo, “Gender Differences in Psychotic Disorders with Concurrent Substance Use,” Journal of Dual Diagnosis, pp. 00–00, 2014. View at Publisher · View at Google Scholar
  • John M. Kane, Cathy Zhao, Brian R. Johnson, Ross A. Baker, Anna Eramo, Robert D. McQuade, Anna R. Duca, Raymond Sanchez, and Timothy Peters-Strickland, “Hospitalization Rates in Patients Switched From Oral Antipsychotics to Aripiprazole Once-Monthly: Final Efficacy Analysis,” Journal of Medical Economics, pp. 1–20, 2014. View at Publisher · View at Google Scholar
  • Onur Baser, Lin Xie, Jacqueline Pesa, and Mike Durkin, “Healthcare Utilization and Costs of Veterans Health Administration Patients with Schizophrenia Treated with Paliperidone Palmitate Long-Acting Injection or Oral Atypical Antipsychotics,” Journal of Medical Economics, pp. 1–21, 2014. View at Publisher · View at Google Scholar
  • Mary V. Seeman, “Substitute Consent in Women with Psychosis,” Journal Of Psychiatric Practice, vol. 20, no. 6, pp. 491–497, 2014. View at Publisher · View at Google Scholar
  • Ridha Joober, “Medium range cognitive impairment (MeRCI) hypothesis for psychosis formation: evidence from epidemiological studies and recent molecular genetic developments,” Journal of Psychiatry & Neuroscience, vol. 39, no. 4, pp. 219–222, 2014. View at Publisher · View at Google Scholar
  • Ana Calvo, Miguel Moreno, Ana Ruiz-Sancho, Marta Rapado-Castro, Carmen Moreno, Teresa Sánchez-Gutiérrez, Celso Arango, and María Mayoral, “Intervention for Adolescents With Early Onset Psychosis and Their Families: A Randomized Controlled Trial,” Journal of the American Academy of Child & Adolescent Psychiatry, 2014. View at Publisher · View at Google Scholar
  • A. Dammak, M. Stiti, and M.N. Vacheron, “Stabilisation des patients schizophrènes en post-aigu : de l’hôpital à la cité,” L'Encéphale, 2014. View at Publisher · View at Google Scholar